Bias in estimating the causal hazard ratio when using two-stage instrumental variable methods

被引:27
作者
Wan, Fei [1 ]
Small, Dylan [2 ]
Bekelman, Justin E. [3 ]
Mitra, Nandita [1 ]
机构
[1] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Stat, Philadelphia, PA 19104 USA
[3] Univ Penn, Abramson Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19104 USA
关键词
instrumental variable; two-stage residual inclusion; two-stage predictor substitution; unmeasured confounding; survival; bias; ADVANCED PROSTATE-CANCER; ANDROGEN-DEPRIVATION THERAPY; INFERENCE; MODELS; IDENTIFICATION; NONCOMPLIANCE; RADIOTHERAPY; TRIAL;
D O I
10.1002/sim.6470
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Two-stage instrumental variable methods are commonly used to estimate the causal effects of treatments on survival in the presence of measured and unmeasured confounding. Two-stage residual inclusion (2SRI) has been the method of choice over two-stage predictor substitution (2SPS) in clinical studies. We directly compare the bias in the causal hazard ratio estimated by these two methods. Under a principal stratification framework, we derive a closed-form solution for asymptotic bias of the causal hazard ratio among compliers for both the 2SPS and 2SRI methods when survival time follows the Weibull distribution with random censoring. When there is no unmeasured confounding and no always takers, our analytic results show that 2SRI is generally asymptotically unbiased, but 2SPS is not. However, when there is substantial unmeasured confounding, 2SPS performs better than 2SRI with respect to bias under certain scenarios. We use extensive simulation studies to confirm the analytic results from our closed-form solutions. We apply these two methods to prostate cancer treatment data from Surveillance, Epidemiology and End Results-Medicare and compare these 2SRI and 2SPS estimates with results from two published randomized trials. Copyright (c) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:2235 / 2265
页数:31
相关论文
共 19 条
  • [1] Semiparametric instrumental variable estimation of treatment response models
    Abadie, A
    [J]. JOURNAL OF ECONOMETRICS, 2003, 113 (02) : 231 - 263
  • [2] Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629
  • [3] Effectiveness of Androgen-Deprivation Therapy and Radiotherapy for Older Men With Locally Advanced Prostate Cancer
    Bekelman, Justin E.
    Mitra, Nandita
    Handorf, Elizabeth A.
    Uzzo, Robert G.
    Hahn, Stephen A.
    Polsky, Daniel
    Armstrong, Katrina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07) : 716 - 722
  • [4] Cais B, 2011, STAT MED, V30, P1809
  • [5] Estimating the effect of treatment in a proportional hazards model in the presence of non-compliance and contamination
    Cuzick, Jack
    Sasieni, Peter
    Myles, Jonathan
    Tyrer, Jonathan
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2007, 69 : 565 - 588
  • [6] Use of Radical Cystectomy for Patients With Invasive Bladder Cancer
    Gore, John L.
    Litwin, Mark S.
    Lai, Julie
    Yano, Elizabeth M.
    Madison, Rodger
    Setodji, Claude
    Adams, John L.
    Saigal, Christopher S.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (11): : 802 - 811
  • [7] Comparative Effectiveness of Prostate Cancer Treatments: Evaluating Statistical Adjustments for Confounding in Observational Data
    Hadley, Jack
    Yabroff, K. Robin
    Barrett, Michael J.
    Penson, David F.
    Saigal, Christopher S.
    Potosky, Arnold L.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (23): : 1780 - 1793
  • [8] Instruments for causal inference -: An epidemiologist's dream?
    Hernán, MA
    Robíns, JM
    [J]. EPIDEMIOLOGY, 2006, 17 (04) : 360 - 372
  • [9] IDENTIFICATION AND ESTIMATION OF LOCAL AVERAGE TREATMENT EFFECTS
    IMBENS, GW
    ANGRIST, JD
    [J]. ECONOMETRICA, 1994, 62 (02) : 467 - 475
  • [10] Nies H, 2011, BIOMETRICS, V67, P1397